Clinical and molecular heterogeneity are hallmarks of chronic lymphocytic leukemia (CLL), a neoplasm characterized by accumulation of mature and clonal long-lived CD5 + B-lymphocytes. The gene discussed is CD5; the disease is B-cell chronic lymphocytic leukemia.